Integrated BioPharma holds 2023 annual meeting; elects Class II directors, approves advisory pay vote, ratifies auditor

INTEGRATED BIOPHARMA INC

Christina Kay, Robert Canarick, and William H. Milmoe elected as Class II directors to serve until 2026.
Non-binding advisory vote on executive compensation approved: 19,964,583 for, 2,510,524 against, 1,715 abstain.
Ratification of Marcum LLP as independent auditor for FY ending June 30, 2024 passed: 23,762,534 for, 7,281 against.
Vote results: Kay 20,393,822 for; Canarick 22,301,725 for; Milmoe 22,285,400 for.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

INTEGRATED BIOPHARMA INC shareholders approved Election of Class II directors for a three-year term at the 2023-11-27 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-11-27

Exact text from the filing

Christina Kay 20,393,822 2,083,000 1,292,993 Robert Canarick 22,301,725 175,097 1,292,993 William H Milmoe 22,285,400 191,422 1,292,993

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

INTEGRATED BIOPHARMA INC shareholders approved Ratify the appointment of Marcum LLP as the Company’s independent auditors for fiscal year ending June 30, 2024 at the 2023-11-27 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-11-27

Exact text from the filing

For Against Abstain 23,762,534 7,281 -

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

INTEGRATED BIOPHARMA INC shareholders approved Non-binding, Advisory Vote on Executive Compensation at the 2023-11-27 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-11-27

Exact text from the filing

For Against Abstain Broker Non-Votes 19,964,583 2,510,524 1,715 1,292,993

View on SEC.gov

Browse all shareholder votes →

INTEGRATED BIOPHARMA INC filing history →

Source: SEC EDGAR

accession 0001437749-23-033049

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.